Improving the Safety of Major Resection for Hepatobiliary Malignancy: Portal Vein Embolization and Recent Innovations in Liver Regeneration Strategies.


Journal

Current oncology reports
ISSN: 1534-6269
Titre abrégé: Curr Oncol Rep
Pays: United States
ID NLM: 100888967

Informations de publication

Date de publication:
16 05 2020
Historique:
entrez: 17 5 2020
pubmed: 18 5 2020
medline: 24 8 2021
Statut: epublish

Résumé

For three decades, portal vein embolization (PVE) has been the "gold-standard" strategy to hypertrophy the anticipated future liver remnant (FLR) in advance of major hepatectomy. During this time, CT volumetry was the most common method to preoperatively assess FLR quality and function and used to determine which patients are appropriate surgical candidates. This review provides the most up-to-date methods for preoperatively assessing the anticipated FLR and summarizes data from the currently available strategies used to induce FLR hypertrophy before surgery for hepatobiliary malignancy. Functional and physiological imaging is increasingly replacing standard CT volumetry as the method of choice for preoperative FLR assessment. PVE, associating liver partition and portal vein ligation, radiation lobectomy, and liver venous deprivation are all currently available techniques to hypertrophy the FLR. Each strategy has pros and cons based on tumor type, extent of resection, presence or absence of underlying liver disease, age, performance status, complication rates, and other factors. Numerous strategies can lead to FLR hypertrophy and improve the safety of major hepatectomy. Which is best has yet to be determined.

Identifiants

pubmed: 32415401
doi: 10.1007/s11912-020-00922-x
pii: 10.1007/s11912-020-00922-x
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

59

Auteurs

David C Madoff (DC)

Department of Radiology and Biomedical Imaging, Section of Interventional Radiology, Yale School of Medicine, New Haven, CT, USA. david.madoff@yale.edu.

Bruno C Odisio (BC)

Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Erik Schadde (E)

Department of Surgery, Rush University Medical Center, Chicago, IL, USA.
Department of Surgery, Cantonal Hospital Winterthur, Zurich, Switzerland.
Institute of Physiology, Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland.

Ron C Gaba (RC)

Department of Radiology, Interventional Radiology Section, University of Illinois Hospital, Chicago, IL, USA.

Roelof J Bennink (RJ)

Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Thomas M van Gulik (TM)

Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Boris Guiu (B)

Department of Radiology, St-Eloi University Hospital-Montpellier, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH